Egetis Therapeutics AB Stock
Stocks
EGTX
SE0003815604
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.940 SEK | -0.72% |
|
+13.58% | +29.96% |
| Market Cap | 3.23B 339M 294M 275M 251M 472M 32.38B 480M 1.26B 16.17B 1.27B 1.25B 54.45B | P/E 2026 * |
476x | P/E 2027 * | -21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 2.73B 288M 249M 233M 213M 400M 27.44B 407M 1.07B 13.7B 1.08B 1.06B 46.14B | EV / Sales 2026 * |
6.23x | EV / Sales 2027 * | 8.2x |
| Free-Float |
40.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Egetis Therapeutics AB
| 1 day | -0.72% | ||
| 1 week | +13.58% | ||
| Current month | +15.67% | ||
| 1 month | +14.14% | ||
| 3 months | +7.10% | ||
| 6 months | +34.24% | ||
| Current year | +29.96% |
| 1 week | 6.39 |  | 7.21 |
| 1 month | 5.86 | | 7.21 |
| Current year | 4.23 | | 7.21 |
| 1 year | 3.62 | | 7.21 |
| 3 years | 3.02 | | 9.3 |
| 5 years | 3 | | 9.3 |
| 10 years | 3 | | 50.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 50 | 2017-06-15 | |
Yilmaz Mahshid
DFI | Director of Finance/CFO | 47 | 2017-12-30 |
Tiago Nune
CTO | Chief Tech/Sci/R&D Officer | - | 2026-04-30 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2016-12-31 | |
| Director/Board Member | 65 | 2016-12-31 | |
Mats Blom
CHM | Chairman | 61 | 2024-05-05 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/13/26 | Sell | Chief Executive Officer | -286,071 | 0.0724% | ||
| 5/11/26 | Fiscal year | Chief Financial Officer | 264,880 | 0.0670% | ||
| 1/16/26 | Buy | Chairman | 150,000 | 0.0380% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.72% | +13.58% | +20.07% | +56.66% | 343M | |
| -0.70% | +24.68% | +76.72% | +103.05% | 70.85B | |
| -2.35% | +3.71% | +31.77% | +63.89% | 55.41B | |
| -1.62% | +34.66% | +21.01% | +483.49% | 29.43B | |
| -0.30% | +18.51% | +56.61% | +4.86% | 24.12B | |
| 0.00% | +0.60% | -16.89% | -12.00% | 23.31B | |
| +0.05% | +7.96% | +44.21% | -22.57% | 18.37B | |
| +9.77% | +25.32% | +252.40% | +442.16% | 16.99B | |
| 0.00% | +10.84% | +31.14% | +628.97% | 16.1B | |
| -3.08% | -6.77% | +36.08% | +142.70% | 13.12B | |
| Average | +0.10% | +352.32% | +55.31% | +189.12% | 26.81B | |
| Weighted average by Cap. | -0.40% | +348.73% | +55.47% | +164.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 439M 46.14M 39.93M 37.38M 34.13M 64.2M 4.4B 65.31M 172M 2.2B 173M 169M 7.4B | 353M 37.09M 32.1M 30.05M 27.44M 51.61M 3.54B 52.51M 138M 1.77B 139M 136M 5.95B |
| Net income | 302M 31.79M 27.52M 25.76M 23.52M 44.25M 3.03B 45.01M 118M 1.52B 119M 117M 5.1B | -95.62M -10.05M -8.7M -8.15M -7.44M -13.99M -959M -14.23M -37.42M -479M -37.75M -36.93M -1.61B |
| Net Debt | -492M -51.76M -44.8M -41.93M -38.29M -72.02M -4.94B -73.27M -193M -2.47B -194M -190M -8.31B | -334M -35.12M -30.4M -28.46M -25.98M -48.88M -3.35B -49.72M -131M -1.67B -132M -129M -5.64B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-08-11 | SEK 6.940 | -0.72% | 340,386 |
| 26-08-10 | SEK 6.990 | -1.27% | 1,121,387 |
| 26-08-07 | SEK 7.080 | +3.36% | 1,256,588 |
| 26-08-06 | SEK 6.850 | +1.63% | 731,610 |
| 26-08-05 | SEK 6.740 | +5.64% | 803,369 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EGTX Stock
Select your edition
All financial news and data tailored to specific country editions
